Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Head & Neck 2Gastrointestinal 2Breast 2Other solid neoplasm 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 17Head and Neck Neoplasms 10Melanoma 9Carcinoma, Non-Small-Cell Lung 8Neoplasms 6Neoplasm Metastasis 6Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5Breast Neoplasms 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Ovarian Neoplasms 4Mouth Neoplasms 4Colorectal Neoplasms 4Carcinoma, Merkel Cell 4Carcinoma, Hepatocellular 4Pancreatic Neoplasms 3Oropharyngeal Neoplasms 3Laryngeal Neoplasms 3Colonic Neoplasms 3Thyroid Neoplasms 2Thyroid Carcinoma, Anaplastic 2Sarcoma 2Recurrence 2Prostatic Neoplasms 2Kidney Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Renal Cell 2Carcinoma 2

Interventions

Surveys and Questionnaires 4Nivolumab 3pembrolizumab 2cemiplimab 2atezolizumab 2amminedichloro(2-methylpyridine)platinum(II) 2Blood Specimen Collection 2trastuzumab deruxtecan 1trametinib 1repotrectinib 1pralsetinib 1pazopanib 1motexafin gadolinium 1durvalumab 1dabrafenib 1avelumab 1alectinib 1Transurethral Resection of Prostate 1Tomography, X-Ray Computed 1Reverse Transcriptase Polymerase Chain Reaction 1Radiosurgery 1Quality of Life 1Patient-Specific Modeling 1Oncolytic Virotherapy 1Ocoxin 1Observation 1Mass Screening 1MLN 8237 1Immune Checkpoint Inhibitors 1Hyperspectral Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × cemiplimab × Head & Neck × Clear all
NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Jules Bordet Institute

Phase 2 Unknown
441 enrolled
BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT04460456 2022-06-30

A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors

Silverback Therapeutics

Phase 1 Unknown
58 enrolled
BreastGastrointestinalGynecologicHead & NeckThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡